New vaccine research center opens; Vietnam moves to prevent human bird flu cases;

Vaccine Research

A major new vaccine research center has opened at Oxford University. Report

Researchers at the University of Texas at San Antonio have won a $1.8 million NIH grant to study a new vaccine for Chlamydia. Story

Vaccine market

Vietnam has begun to take emergency measures to prevent bird flu in animals from jumping to humans. The virus has been found in birds in seven of the country's provinces. Report

Doctors say that a resistance to Tamiflu and a vaccine that fails to protect people from the circulating B strain has made it hard to contain this year's outbreak of the flu. Story

A Chinese pharma company says that it has retrieved most of the rabies vaccine it began hunting for after a test revealed a dangerous ingredient in the jab. Story

Novartis Vaccines and Diagnostics has voluntarily withdrawn five lots of the seasonal flu vaccine Fluvirin after tests revealed variations of potency. Story

Human Genome Sciences has begun shipping doses of ABthrax in a deal that's worth at least $150 million. The doses are being stockpiled in the U.S. Report

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.